MA26894A1 - Agents antihypertenseurs et leur utilisation - Google Patents

Agents antihypertenseurs et leur utilisation

Info

Publication number
MA26894A1
MA26894A1 MA26872A MA26872A MA26894A1 MA 26894 A1 MA26894 A1 MA 26894A1 MA 26872 A MA26872 A MA 26872A MA 26872 A MA26872 A MA 26872A MA 26894 A1 MA26894 A1 MA 26894A1
Authority
MA
Morocco
Prior art keywords
antihypertensive agents
antihypertensive
agents
Prior art date
Application number
MA26872A
Other languages
English (en)
Inventor
Bruce Jeffrey Auerbach
Karen Diane Hitchcock
Michael John Ryan
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of MA26894A1 publication Critical patent/MA26894A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA26872A 2000-04-26 2002-10-17 Agents antihypertenseurs et leur utilisation MA26894A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19985500P 2000-04-26 2000-04-26
US24228000P 2000-10-20 2000-10-20

Publications (1)

Publication Number Publication Date
MA26894A1 true MA26894A1 (fr) 2004-12-20

Family

ID=26895229

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26872A MA26894A1 (fr) 2000-04-26 2002-10-17 Agents antihypertenseurs et leur utilisation

Country Status (34)

Country Link
EP (1) EP1280522B1 (fr)
JP (1) JP2003531170A (fr)
KR (1) KR20020091245A (fr)
CN (1) CN1426299A (fr)
AP (1) AP2002002665A0 (fr)
AR (1) AR031104A1 (fr)
AT (1) ATE283691T1 (fr)
AU (1) AU2001247658A1 (fr)
BG (1) BG107264A (fr)
BR (1) BR0110234A (fr)
CA (1) CA2405559A1 (fr)
CZ (1) CZ20023459A3 (fr)
DE (1) DE60107559T2 (fr)
DO (1) DOP2001000150A (fr)
EA (1) EA005245B1 (fr)
EE (1) EE200200611A (fr)
ES (1) ES2231470T3 (fr)
HR (1) HRP20020936A2 (fr)
HU (1) HUP0300403A3 (fr)
IL (1) IL152474A0 (fr)
IS (1) IS6570A (fr)
MA (1) MA26894A1 (fr)
MX (1) MXPA02009662A (fr)
NO (1) NO20025135L (fr)
NZ (1) NZ521713A (fr)
OA (1) OA12252A (fr)
PA (1) PA8516001A1 (fr)
PE (1) PE20011308A1 (fr)
PL (1) PL357906A1 (fr)
PT (1) PT1280522E (fr)
SK (1) SK15132002A3 (fr)
SV (1) SV2002000367A (fr)
TN (1) TNSN01061A1 (fr)
WO (1) WO2001080847A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1481962A1 (fr) * 1997-12-12 2004-12-01 Warner-Lambert Company LLC Nouveau carboxyéthylether reduisant la cholesterolémie
BRPI0812597A2 (pt) * 2007-06-21 2015-02-18 Actimis Pharmaceuticals Inc Sal, composição farmacêutica, métodos para o tratamento, prevenção ou melhora de um ou mais sintomas de uma doença mediada por crth2, de uma doença relacionada com eosinófilo, de uma doença relacionada com basófilo, e de uma doença inflamatória, e, processo para a preparação do sal
DE102008026033B4 (de) * 2008-05-30 2017-08-24 Voith Patent Gmbh Antriebsstrang mit einer hydrodynamischen Maschine
SI23149A (sl) * 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
US5648387A (en) * 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
NZ503982A (en) * 1997-12-12 2002-03-28 Warner Lambert Co Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus

Also Published As

Publication number Publication date
WO2001080847A3 (fr) 2002-07-18
IS6570A (is) 2002-09-27
PA8516001A1 (es) 2002-09-17
HRP20020936A2 (en) 2004-12-31
EP1280522A2 (fr) 2003-02-05
TNSN01061A1 (en) 2005-11-10
AU2001247658A1 (en) 2001-11-07
IL152474A0 (en) 2003-05-29
BR0110234A (pt) 2003-03-05
DOP2001000150A (es) 2002-08-15
AP2002002665A0 (en) 2002-12-31
MXPA02009662A (es) 2003-03-10
PE20011308A1 (es) 2002-01-18
SK15132002A3 (sk) 2003-08-05
JP2003531170A (ja) 2003-10-21
PT1280522E (pt) 2005-02-28
NZ521713A (en) 2004-09-24
WO2001080847A2 (fr) 2001-11-01
CZ20023459A3 (cs) 2003-05-14
EA005245B1 (ru) 2004-12-30
EP1280522B1 (fr) 2004-12-01
OA12252A (en) 2006-05-11
AR031104A1 (es) 2003-09-10
NO20025135L (no) 2002-11-27
CA2405559A1 (fr) 2001-11-01
BG107264A (en) 2003-07-31
SV2002000367A (es) 2002-08-26
NO20025135D0 (no) 2002-10-25
ES2231470T3 (es) 2005-05-16
DE60107559D1 (de) 2005-01-05
HUP0300403A2 (hu) 2003-06-28
CN1426299A (zh) 2003-06-25
KR20020091245A (ko) 2002-12-05
DE60107559T2 (de) 2005-04-14
EE200200611A (et) 2004-06-15
HUP0300403A3 (en) 2005-03-29
ATE283691T1 (de) 2004-12-15
EA200200953A1 (ru) 2003-04-24
PL357906A1 (en) 2004-08-09

Similar Documents

Publication Publication Date Title
MA26348A1 (fr) 2-thio-3,5-dicyano-4-phenyl-6-aminopyridine substituees et leur utilisation
DE50112013D1 (de) Deodorantien und antiperspirantien
DE60135173D1 (de) Spielsystem und computerlesbares Speichermedium
DE60142955D1 (de) Batterieladeverfahren und batterieblock
NO20023616L (no) Ny anvendelse
MA25688A1 (fr) 2-thio-3, 5-dicyano-4-aryl-6-aminopyridines substituees et leur utilisation.
DE69942067D1 (de) Vliesstoff
IS6411A (is) Kaspasa tálmar og notkun þeirra
DE60111534D1 (de) Alpha-acyl- und alpha-heteroatom-substituierte benzenacetamide verwendbar als glucokinase-aktivatoren
ATE236898T1 (de) S-omeprazol in festform
NO20005503D0 (no) Ny anvendelse
ID30590A (id) Celana sekali pakai jenis-celana pendek
DE60131797D1 (de) Spielsystem und entsprechendes computerlesbares Aufzeichungsmedium
DE69903961D1 (de) Muscarinagonisten und antagonisten
FI20001715A0 (fi) Rankoihin liittyvät järjestelyt ja menetelmät
DE50112472D1 (de) Abstreifer und Gutförderer
NO20031354L (no) Benzodiazepinderivater
EE05084B1 (et) N-(heterotskll)benseen- v?i -pridiinsulfoonamiidid kui tromboosi- ja hbimisvastased ained
MA26894A1 (fr) Agents antihypertenseurs et leur utilisation
NO20024617D0 (no) Aryl- og heteroarylsulfonater
DE60117096D1 (de) Dihydroindol- und tetrahydrochinolinderivate
DE60121845D1 (de) Spielsystem und entsprechendes computerlesbares Aufzeichungsmedium
FR2815229B1 (fr) Cendrier portable
SE0004405D0 (sv) New composition and use
SE9903962D0 (sv) Ny användning